Ad-mediated delivery of MDA-7/IL-24/CTV is very efficient in inhibiting tumor growth when delivered intratumorally, however, systemic administration of these therapeutic viruses may be necessary to achieve maximum benefit and for better disease control. This evidence concerns the gene IL24 and neoplasm.